VYNE Therapeutics (VYNE) Misses Q1 EPS by 20c

VYNE Therapeutics (NASDAQ: VYNE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $200 thousand.

For earnings history and earnings-related data on VYNE Therapeutics (VYNE) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Boeing and Bell Boeing receive defense contracts totaling $56.4M
• OpenAI says its agents leaked some user images - Reuters